Simon Quick Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,175
Closed -$138K 253
2022
Q1
$138K Buy
1,175
+440
+60% +$49.4K 0.04% 123
2021
Q4
$95K Sell
735
-1,099
-60% -$128K 0.03% 165
2021
Q3
$207K Buy
1,834
+1,099
+150% +$125K 0.05% 119
2021
Q2
$76K Hold
735
0.02% 180
2021
Q1
$61K Hold
735
0.02% 210
2020
Q4
$67K Sell
735
-1,476
-67% -$122K 0.02% 173
2020
Q3
$176K Buy
2,211
+348
+19% +$27.2K 0.05% 92
2020
Q2
$129K Buy
1,863
+75
+4% +$5.33K 0.05% 107
2020
Q1
$112K Buy
1,788
+39
+2% +$2.81K 0.04% 112
2019
Q4
$136K Buy
1,749
+714
+69% +$55.8K 0.05% 117
2019
Q3
$76K Buy
1,035
+612
+145% +$43K 0.03% 137
2019
Q2
$26K Sell
423
-1,002
-70% -$60.6K 0.01% 161
2019
Q1
$91K Hold
1,425
0.04% 127
2018
Q4
$73K Buy
1,425
+600
+73% +$30.4K 0.03% 142
2018
Q3
$48K Sell
825
-450
-35% -$22K 0.02% 177
2018
Q2
$61K Sell
1,275
-1,275
-50% -$59.5K 0.03% 157
2018
Q1
$119K Buy
2,550
+975
+62% +$42.3K 0.05% 122
2017
Q4
$66K Hold
1,575
0.03% 194
2017
Q3
$57K Buy
+1,575
New +$60.1K 0.02% 253

Other funds holding EW

Simon Quick Advisors's EW Position: Q2 2022 in Review

Simon Quick Advisors sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 1,175 shares — an estimated $138K sold.

Simon Quick Advisors first reported a position in EW in Q3 2017 and held it in 19 quarters. The position peaked at $207K in Q3 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Simon Quick Advisors reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Simon Quick Advisors sold 1,175 Edwards Lifesciences shares in Q2 2022, an estimated $138K.
  • Simon Quick Advisors first reported a position in Edwards Lifesciences in Q3 2017 and held it in 19 quarters.
  • Simon Quick Advisors's Edwards Lifesciences position peaked at $207K in Q3 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.